Zoledronat-Teva onco 4 mg/ 5 ml
As listed in the register: Zoledronat-Teva onco 4 mg/ 5 ml, Konzentrat zur Herstellung einer Infusionslösung
4 mg/ 5 ml ·
- Prescription only
- Muscles, joints and bones
- Active substance
- Acidum zoledronicum
- Used in
- Muscles, joints and bones
- Made by
- Teva Pharma AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Knochenmetastasen solider Tumoren und multiples Myelom, maligne Hypercalcämie
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Teva Pharma AG |
|---|---|
| Active substance | Acidum zoledronicum |
| Used in | Muscles, joints and bones |
| Strength | 4 mg/ 5 ml |
| Classification | M05BA08 · Muscles, joints and bones |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Zoledronat-Teva onco 4 mg/ 5 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 62200 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.